EXHIBIT 2.1 ----------- CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. AGREEMENT FOR PURCHASE AND SALE OF SINGLE-CHAIN POLYPEPTIDE BUSINESS This Purchase Agreement and Sale...Purchase and Sale Agreement • July 2nd, 2001 • Curis Inc • Biological products, (no disgnostic substances) • Massachusetts
LETTER OF INTENTLetter of Intent • July 2nd, 2001 • Curis Inc • Biological products, (no disgnostic substances)
The Parties intend to enter into two further agreements, a Target Research and License Agreement and a Development Agreement, within the next two weeks (extendible by mutual agreement). Under the Development Agreement, the Parties will jointly develop therapeutic antibody(ies). The agreement may provide either party the option to withdraw from the project at certain agreed time points. In that case, the other party may develop the antibody on its own or with a partner, and the Parties agree that, to the extent possible, all Curis or Micromet Patent Rights relevant to the Therapeutic Antibody will be licensed or sublicensed to the Party continuing development, to the extent necessary for such continued development.
